Revista Portuguesa de Cardiologia (English Edition)最新文献

{"title":"Intracavitary mass in echocardiography: A rare manifestation of serous ovarian carcinoma","authors":"Arnold Mendez-Toro , Andres Felipe Linares-Vaca","doi":"10.1016/j.repce.2020.09.010","DOIUrl":"10.1016/j.repce.2020.09.010","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 701-702"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2020.09.010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39402029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient adherence to direct oral anticoagulants: To take or not to take, is it a patient's choice?","authors":"Cristina Gavina","doi":"10.1016/j.repce.2021.08.008","DOIUrl":"10.1016/j.repce.2021.08.008","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 677-678"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2021.08.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39402077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical value of the combined use of P-wave dispersion and troponin values to predict atrial fibrillation recurrence in patients with paroxysmal atrial fibrillation","authors":"Metin Ocak ,&nbsp;Mustafa Begenc Tascanov","doi":"10.1016/j.repce.2020.10.022","DOIUrl":"10.1016/j.repce.2020.10.022","url":null,"abstract":"<div><h3>Introduction</h3><p>P-wave dispersion (PWD) and cardiac troponin levels are independently associated with the recurrence of atrial fibrillation (AF) in patients with paroxysmal AF (PAF). We investigated the clinical usefulness of combining PWD and cardiac troponin I to predict AF recurrence in patients presenting to the emergency department with PAF.</p></div><div><h3>Methods</h3><p>This study included 65 patients with PAF who were divided into three groups according to baseline troponin I and PWD values (group 1, troponin I&lt;0.11 ng/dl and PWD&lt;44.5 ms; group II, troponin I&lt;0.11 ng/dl and PWD≥44.5 ms, or troponin I≥0.11 ng/dl and PWD&lt;44.5 ms; group III, troponin I≥0.11 ng/dl and PWD≥44.5 ms).</p></div><div><h3>Results</h3><p>The AF recurrence rate was significantly higher in group III than in groups I and II. Multivariate analysis revealed that the troponin I and PWD values in group III (odds ratio: 7.236, 95% confidence interval: 1.879-27.861, p=0.004) were independent predictors of AF recurrence.</p></div><div><h3>Conclusions</h3><p>The combined use of PWD and basal troponin I levels is a better predictor of AF recurrence than either value alone.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 679-684"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2020.10.022","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39402078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction","authors":"José Silva-Cardoso ,&nbsp;Aurora Andrade ,&nbsp;Dulce Brito ,&nbsp;Jorge Ferreira ,&nbsp;Cândida Fonseca ,&nbsp;Marisa Peres ,&nbsp;Fátima Franco ,&nbsp;Brenda Moura","doi":"10.1016/j.repce.2021.02.006","DOIUrl":"10.1016/j.repce.2021.02.006","url":null,"abstract":"<div><p>Heart failure (HF) is a major health problem with a significant impact on morbidity, mortality, quality of life and healthcare costs. Despite the positive impact of disease-modifying therapies developed over the last four decades, HF mortality and hospitalization remain high.</p><p>We aim at reviewing the evidence supporting the use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors, as a novel strategy for HF with reduced ejection fraction (HFrEF) treatment.</p><p>The consistent observation of a reduction in HF hospitalizations in type-2 diabetes cardiovascular safety trials EMPA-REG OUTCOME, CANVAS, DECLARE-TIMI 58 and VERTIS raised the hypothesis that SGLT-2 inhibitors could have an impact in HF treatment.</p><p>This hypothesis was first confirmed in 2019 with the DAPA-HF publication showing that dapagliflozin on top of optimized HFrEF therapy, reduced HF-hospitalizations and cardiovascular mortality. This was reinforced by the EMPEROR-Reduced publication in 2020 showing that empagliflozin on top of optimized HFrEF therapy, reduced HF-hospitalizations. Both studies established SGLT-2 inhibitors as a fourth pillar of HFrEF prognosis-modifying therapy, in addition to the gold standard triple neurohormonal modulation/blockade.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 687-693"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2021.02.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10339767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Massive thrombus over an aneurysmatic left main coronary artery: Non-interventional therapy?","authors":"Kristian Rivera,&nbsp;Diego Fernández-Rodríguez,&nbsp;Marta Zielonka,&nbsp;Juan Casanova-Sandoval","doi":"10.1016/j.repce.2020.07.023","DOIUrl":"10.1016/j.repce.2020.07.023","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 699-700"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2020.07.023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39402027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Heaven can wait… for lipid control in very high cardiovascular risk patients","authors":"Alberto Mello e Silva","doi":"10.1016/j.repce.2021.08.005","DOIUrl":"10.1016/j.repce.2021.08.005","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 649-651"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2021.08.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39404249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Balloon pulmonary angioplasty protocol in a Portuguese pulmonary hypertension expert center","authors":"Rita Calé ,&nbsp;Filipa Ferreira ,&nbsp;Ana Rita Pereira ,&nbsp;Carla Saraiva ,&nbsp;Ana Santos ,&nbsp;Sofia Alegria ,&nbsp;Débora Repolho ,&nbsp;Sílvia Vitorino ,&nbsp;Pedro Santos ,&nbsp;Gonçalo Morgado ,&nbsp;Philippe Brenot ,&nbsp;Maria José Loureiro ,&nbsp;Hélder Pereira","doi":"10.1016/j.repce.2020.11.026","DOIUrl":"10.1016/j.repce.2020.11.026","url":null,"abstract":"<div><h3>Introduction</h3><p>Balloon pulmonary angioplasty (BPA) has emerged as a promising therapeutic option for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are not eligible for pulmonary thromboendarterectomy (PEA) or who have recurrent or persistent pulmonary hypertension after surgery. There is no standardized technique for BPA and, its complexity and high risk of severe complications, requires skills and appropriate training and should be reserved for expert CTEPH centers, as a complementary intervention to medical and surgical therapy.</p></div><div><h3>Objective</h3><p>The purpose of this document is to describe the BPA protocol used at a high-volume center nationwide, validated by its results.</p></div><div><h3>Methods</h3><p>The present protocol includes technical details, definition of outcomes and complications, as well as patient full diagnostic work-up and treatment algorithm, before and after BPA.</p></div><div><h3>Results</h3><p>The technical, hemodynamic, and clinical results of the application of this protocol will be subject of a later publication where they will be described in detail. In conclusion, we present a percutaneous intervention protocol in the treatment of pulmonary hypertension in the context of chronic pulmonary thromboembolism, validated by its clinical, hemodynamic, and technical results.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 653-665"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2020.11.026","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39404250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Serum biomarkers and the electrocardiogram: Best friends forever?","authors":"Pedro Silva Cunha","doi":"10.1016/j.repce.2021.08.006","DOIUrl":"10.1016/j.repce.2021.08.006","url":null,"abstract":"","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 685-686"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2021.08.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39402079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exercise-induced left fascicular block: A forgotten sign of coronary disease","authors":"Virginia Ruiz-Pizarro,&nbsp;Julián Palacios-Rubio,&nbsp;Miguel Ángel Cobos-Gil","doi":"10.1016/j.repce.2018.02.025","DOIUrl":"10.1016/j.repce.2018.02.025","url":null,"abstract":"<div><p>A 55-year-old patient presented with stable angina pectoris with normal physical examination on rest electrocardiogram and cardiac echocardiogram. Treadmill test revealed exercise-induced left posterior fascicular block, which is an uncommon and easily unnoticed marker of coronary artery disease. A dobutamine stress echocardiogram was performed, with a clearly positive result. Coronary angiography revealed critical stenosis in the right coronary artery.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 695.e1-695.e4"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2018.02.025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39402083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Temporal trends of lipid control in very high cardiovascular risk patients","authors":"Paulo Maia Araújo ,&nbsp;Alzira Nunes ,&nbsp;Sofia Torres ,&nbsp;Carlos Xavier Resende ,&nbsp;Sérgio Machado Leite ,&nbsp;Joana Duarte Rodrigues ,&nbsp;Sandra Amorim ,&nbsp;Elisabete Martins ,&nbsp;Manuel Campelo ,&nbsp;Maria Júlia Maciel","doi":"10.1016/j.repce.2020.10.021","DOIUrl":"10.1016/j.repce.2020.10.021","url":null,"abstract":"<div><h3>Introduction</h3><p>Since 2011, the European guidelines have included a specific low-density lipoprotein cholesterol (LDL-C) target, &lt;70 mg/dl, for very high cardiovascular risk (CVR) patients. However, registries have shown unsatisfactory results in obtaining this level of adequate lipid control.</p></div><div><h3>Objectives</h3><p>To assess temporal trends in the use of lipid-lowering therapy (LLT) and attainment of adequate control in very high CVR patients since 2011.</p></div><div><h3>Methods</h3><p>We performed a retrospective observational study including very high CVR patients admitted in two periods: the first two years since the 2011 guidelines (2011/2012) and five years later (2016/2017). Lipid values, LLT, clinical variables and adequate lipid control rates were analyzed.</p></div><div><h3>Results</h3><p>A total of 1314 patients were reviewed (2011/2012: 638; 2016/2017: 676). Overall, 443 patients (33.7%) were not under LLT and only a slight improvement in drug prescription was observed from 2011/2012 to 2016/2017. In LLT users, the proportion of high-intensity LLT increased significantly in the later years (6.4% vs. 24.0%; p&lt;0.001), but this was not associated with adequate lipid control. Overall, mean LDL-C was 95.4±37.2 mg/dl and adequate control was achieved in 320 patients (24.4%), without significant differences between 2011/2012 and 2016/2017 (p=0.282). Independent predictors of adequate control were male gender, older age, diabetes, chronic kidney disease, prior acute coronary syndrome, prior stroke and LLT, while stable coronary artery disease was associated with higher risk of failure.</p></div><div><h3>Conclusion</h3><p>Even after the introduction of specific LDL-C targets, these are still not reached in most patients. Over a five-year period, LLT prescription only improved slightly, while adequate lipid control rates remained unchanged.</p></div>","PeriodicalId":101121,"journal":{"name":"Revista Portuguesa de Cardiologia (English Edition)","volume":"40 9","pages":"Pages 641-648"},"PeriodicalIF":0.0,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.repce.2020.10.021","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39404248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}